[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0014804A - Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto - Google Patents

Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto

Info

Publication number
BR0014804A
BR0014804A BR0014804-0A BR0014804A BR0014804A BR 0014804 A BR0014804 A BR 0014804A BR 0014804 A BR0014804 A BR 0014804A BR 0014804 A BR0014804 A BR 0014804A
Authority
BR
Brazil
Prior art keywords
compound
treatment
preparation
pharmaceutical formulation
arrhythmia
Prior art date
Application number
BR0014804-0A
Other languages
English (en)
Inventor
Annika Bjoere
Magnus Bjoersne
David Cladingboel
Kurt-Juergen Hoffman
John Pavey
Fritiof Ponten
Gert Strandlund
Peder Svensson
Colin Thomson
Michael Wilstermann
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BR0014804A publication Critical patent/BR0014804A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

"COMPOSTO, FORMULAçãO FARMACêUTICA, USO DE UM COMPOSTO, MéTODO DE PROFILAXIA OU TRATAMENTO DE UMA ARRITMIA, E, PROCESSO PARA A PREPARAçãO DE UM COMPOSTO". São fornecidos compostos de Fórmula (I) em que R^ 1^, R^ 2^, R^ 3^, R^ 4^, R^ 41^ a R^ 46^, A, B e G têm os significados dados no relatório descritivo, os quais são úteis na profilaxia e no tratamento de arritmias, em particular as arritmias atriais e ventriculares.
BR0014804-0A 1999-10-18 2000-10-13 Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto BR0014804A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903759A SE9903759D0 (sv) 1999-10-18 1999-10-18 Pharmaceutically active compounds
PCT/SE2000/001994 WO2001028992A2 (en) 1999-10-18 2000-10-13 New oxabispidine compounds useful in the treatment of cardiac arrhythmias

Publications (1)

Publication Number Publication Date
BR0014804A true BR0014804A (pt) 2002-06-11

Family

ID=20417401

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014804-0A BR0014804A (pt) 1999-10-18 2000-10-13 Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto

Country Status (41)

Country Link
US (6) US6559143B1 (pt)
EP (2) EP1559717A3 (pt)
JP (3) JP3973906B2 (pt)
KR (1) KR100796142B1 (pt)
CN (2) CN100379743C (pt)
AP (1) AP1536A (pt)
AR (2) AR026064A1 (pt)
AT (1) ATE292134T1 (pt)
AU (1) AU769513B2 (pt)
BG (1) BG65785B1 (pt)
BR (1) BR0014804A (pt)
CA (1) CA2386910A1 (pt)
CO (1) CO5271655A1 (pt)
CU (1) CU23210A3 (pt)
CZ (1) CZ20021328A3 (pt)
DE (1) DE60019158T2 (pt)
DK (1) DK1235831T3 (pt)
EA (1) EA005319B1 (pt)
EE (1) EE04854B1 (pt)
ES (1) ES2239047T3 (pt)
HK (1) HK1049003B (pt)
HR (1) HRP20020336B1 (pt)
HU (1) HUP0204085A3 (pt)
IL (5) IL149108A0 (pt)
IS (2) IS2224B (pt)
MX (1) MXPA02003848A (pt)
MY (1) MY130661A (pt)
NO (1) NO327977B1 (pt)
NZ (2) NZ518156A (pt)
OA (1) OA12067A (pt)
PL (1) PL354970A1 (pt)
PT (1) PT1235831E (pt)
RS (1) RS50760B (pt)
SE (1) SE9903759D0 (pt)
SI (1) SI1235831T1 (pt)
SK (1) SK286723B6 (pt)
TR (1) TR200201059T2 (pt)
TW (1) TWI283680B (pt)
UA (1) UA75052C2 (pt)
WO (1) WO2001028992A2 (pt)
ZA (1) ZA200202575B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
SE9902270D0 (sv) * 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas
SE0101323D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab New process
SE0101327D0 (sv) 2001-04-12 2001-04-12 Astrazeneca Ab New crystalline forms
SE0101324D0 (sv) 2001-04-12 2001-04-12 Astrazeneca Ab New process
TWI259836B (en) * 2001-04-12 2006-08-11 Astrazeneca Ab Modified release formulation suitable for antiarrhythmic compounds
SE0101329D0 (sv) * 2001-04-12 2001-04-12 Astrazeneca Ab Pharmaceutical formulation
AU2002343067A1 (en) * 2001-11-22 2003-06-10 Astrazeneca Ab Process for the preparation of 2-or-9-oxa-3, 7-diazabicyclo (3.3.1) nonanes from 2-aminomethyl-2, 3-dihydrooxazines, intermediates therefore, and processes for preparing such intermediates
SE0201373D0 (sv) * 2002-05-06 2002-05-06 Astrazeneca Ab Combination therapy
SE0201374D0 (sv) * 2002-05-06 2002-05-06 Astrazeneca Ab Pharmaceutical combination
SE0201662D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Pharmaceutical combination
GB0223712D0 (en) 2002-10-14 2002-11-20 Astrazeneca Ab Chemical intermediate
SE0401539D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
SE0401540D0 (sv) 2004-06-15 2004-06-15 Astrazeneca Ab New compounds
KR20080021114A (ko) * 2005-06-13 2008-03-06 아스트라제네카 아베 심부정맥의 치료를 위한 신규한 옥사비스피딘 화합물
CA2610204A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes
WO2006137770A1 (en) * 2005-06-20 2006-12-28 Astrazeneca Ab Process for the preparation of n,n´- disubstituted oxabispidines
AR053901A1 (es) * 2005-06-20 2007-05-23 Astrazeneca Ab Formas fisicas de oxabispidinas n,n'- disustituidas
JP2008546764A (ja) * 2005-06-20 2008-12-25 アストラゼネカ アクチボラグ オキサビスピジンのスルホン酸塩の製造方法
CN1330636C (zh) * 2005-09-26 2007-08-08 鲁南制药集团股份有限公司 盐酸替罗非班中间体的合成方法
TW200734342A (en) * 2005-12-15 2007-09-16 Astrazeneca Ab New compounds for the treatment of cardiac arrhythmias
TW201004963A (en) * 2008-07-03 2010-02-01 Targacept Inc Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
GB2495308B (en) * 2011-10-05 2014-09-10 John Royce Method and apparatus for cleaning a filter
EP2970196B1 (en) 2013-03-15 2020-11-25 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
US10231970B2 (en) 2014-09-30 2019-03-19 NV Heterocycles Methods of producing heteropolycycles via bis-epoxidation

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196154A (en) * 1962-05-17 1965-07-20 Sterling Drug Inc 3-substituted-9-methyl-3, 9-diazabicyclo [3.3.1] nonanes
US3503939A (en) 1967-03-29 1970-03-31 Du Pont Polyamides from heterocyclic diamines
CH488048A (de) 1969-06-12 1970-03-31 Inventa Ag Verfahren zur Herstellung von Polyesterfasern mit verbesserter Gummihaftung
JPS5772977A (en) * 1980-10-23 1982-05-07 Dainippon Ink & Chem Inc Fluorine-containing diepoxy compound and its preparation
DE3112055A1 (de) * 1981-03-27 1982-10-07 Basf Ag, 6700 Ludwigshafen Bispidinderivate, ihre herstellung und diese enthaltende arzneimittel
US4533713A (en) * 1983-05-06 1985-08-06 Minnesota Mining And Manufacturing Company Fluoroaliphaticsulfonamides containing oxirane groups and/or N-β-hydroxyalkylene groups
FI67320C (fi) * 1983-05-09 1985-03-11 Partek Ab Foerfarande och glidgjutanordning foer gjutning av betongstycken
JPS6284070A (ja) 1985-10-07 1987-04-17 Kanegafuchi Chem Ind Co Ltd 新規なグリシジル化合物及びその製造法
JPS6284071A (ja) * 1985-10-07 1987-04-17 Kanegafuchi Chem Ind Co Ltd 新規グリシジル化合物及びその製造方法
DE3732094A1 (de) 1987-09-24 1989-04-06 Basf Ag Bispidinderivate als klasse iii-antiarrhythmika
US5140033A (en) 1989-04-03 1992-08-18 Bayer Aktiengesellschaft Antibacterial 5-alkylquinolonecarboxylic acids
US5110933A (en) 1989-11-13 1992-05-05 Board Of Regents Of Oklahoma State University Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
FR2664270B1 (fr) * 1990-07-09 1994-04-08 Norsolor Sa Nouveaux composes (meth)acryliques porteurs de fonction thiocyanate, leur procede de preparation et leur application a l'obtention de nouveaux polymeres.
JP2602745B2 (ja) * 1991-06-26 1997-04-23 花王株式会社 フレキシブルディスク用センターハブのピッキング装置
US5468858A (en) * 1993-10-28 1995-11-21 The Board Of Regents Of Oklahoma State University Physical Sciences N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents
US5831099A (en) * 1995-03-10 1998-11-03 The United States Of America As Represented By The Secretary Of The Army Compounds of 1,5-disubstituted-3,7 diaza bicyclo 3.3.0! octanes and products containing the same
SE9704709D0 (sv) * 1997-12-17 1997-12-17 Astra Ab Pharmaceutically active compounds
SE9803517D0 (sv) * 1998-10-15 1998-10-15 Astra Ab Pharmaceutical preparation
CA2368829A1 (en) 1999-04-09 2000-10-19 Astrazeneca Ab Adamantane derivatives
SE9902270D0 (sv) * 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE9903759D0 (sv) * 1999-10-18 1999-10-18 Astra Ab Pharmaceutically active compounds
SE9904765D0 (sv) * 1999-12-23 1999-12-23 Astra Ab Pharmaceutically-useful compounds
AR030756A1 (es) * 2000-10-02 2003-09-03 Astrazeneca Ab Compuesto de oxabispidina util en el tratamiento de arritmias cardiacas

Also Published As

Publication number Publication date
IS2224B (is) 2007-04-15
AR026064A1 (es) 2002-12-26
CO5271655A1 (es) 2003-04-30
YU29402A (sh) 2004-12-31
CN1399639A (zh) 2003-02-26
SK5062002A3 (en) 2002-11-06
TR200201059T2 (tr) 2002-09-23
ZA200202575B (en) 2003-09-23
MY130661A (en) 2007-07-31
US7351821B2 (en) 2008-04-01
JP2007204486A (ja) 2007-08-16
US20070117799A1 (en) 2007-05-24
AU1069101A (en) 2001-04-30
JP3973906B2 (ja) 2007-09-12
PL354970A1 (en) 2004-03-22
CN101265262A (zh) 2008-09-17
NO327977B1 (no) 2009-11-02
IL183853A0 (en) 2009-02-11
CU23210A3 (es) 2007-06-20
IL183852A0 (en) 2009-02-11
ATE292134T1 (de) 2005-04-15
US7772229B2 (en) 2010-08-10
ES2239047T3 (es) 2005-09-16
HK1049003B (zh) 2005-09-09
EE04854B1 (et) 2007-06-15
DK1235831T3 (da) 2005-06-27
NZ518156A (en) 2004-05-28
DE60019158D1 (de) 2005-05-04
EE200200203A (et) 2003-06-16
EP1235831B1 (en) 2005-03-30
HUP0204085A3 (en) 2006-01-30
HRP20020336A2 (en) 2004-02-29
NZ531260A (en) 2005-08-26
CA2386910A1 (en) 2001-04-26
SI1235831T1 (pt) 2005-08-31
CZ20021328A3 (cs) 2002-09-11
UA75052C2 (en) 2006-03-15
HUP0204085A2 (hu) 2003-04-28
SK286723B6 (sk) 2009-04-06
KR20020038956A (ko) 2002-05-24
JP2006342182A (ja) 2006-12-21
TWI283680B (en) 2007-07-11
US6559143B1 (en) 2003-05-06
EP1235831A2 (en) 2002-09-04
NO20021811L (no) 2002-06-06
WO2001028992A2 (en) 2001-04-26
NO20021811D0 (no) 2002-04-17
PT1235831E (pt) 2005-06-30
WO2001028992A3 (en) 2001-09-13
JP2003512352A (ja) 2003-04-02
SE9903759D0 (sv) 1999-10-18
KR100796142B1 (ko) 2008-01-21
AU769513B2 (en) 2004-01-29
HK1049003A1 (en) 2003-04-25
IS6346A (is) 2002-04-17
IL149108A (en) 2009-12-24
EP1559717A2 (en) 2005-08-03
AP1536A (en) 2006-01-09
CN100379743C (zh) 2008-04-09
US7164017B2 (en) 2007-01-16
MXPA02003848A (es) 2002-10-23
AP2002002471A0 (en) 2002-06-30
DE60019158T2 (de) 2006-02-02
EP1559717A3 (en) 2009-04-29
EA200200390A1 (ru) 2002-10-31
US20090326221A1 (en) 2009-12-31
AR039226A2 (es) 2005-02-09
US20030153564A1 (en) 2003-08-14
US20060166980A1 (en) 2006-07-27
OA12067A (en) 2006-05-04
IS8586A (is) 2006-12-27
IL183854A0 (en) 2009-02-11
RS50760B (sr) 2010-08-31
EA005319B1 (ru) 2005-02-24
HRP20020336B1 (en) 2006-02-28
US20060166979A1 (en) 2006-07-27
IL149108A0 (en) 2002-11-10
BG65785B1 (bg) 2009-11-30
BG106588A (en) 2003-01-31

Similar Documents

Publication Publication Date Title
BR0014804A (pt) Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto
BR9813668A (pt) Composto, uso do mesmo, processo para prepará-lo, formulação farmacêutica, e, processo de profilaxia ou tratamento de uma arritmia
BR0016678A (pt) Composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto
BR0206791A (pt) Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto
BRPI0713457A2 (pt) composto, uso do mesmo, composição farmacêutica, método de tratamento de arritmias, agente para o tratamento de arritmias, e, processo para preparar um composto
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
CY1106178T1 (el) 2’- υποκατεστημενα 1,1’-διφαινυλο-2-καρβοξαμιδια, μεθοδος για την παρασκευη τους, η χρηση τους ως φαρμακου καθως και φαρμακευτικα παρασκευασματα που τα πepιεχουν
BR9808953A (pt) Composto, processo para tratar um distúrbio mediado pela ciclooxigenase-2 em um paciente, e, composição farmacêutica
BR9907270A (pt) Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto
BR0014695A (pt) 5-(2-substituìdo-5-heterociclilsulfonilpirid-3-il)-dihi dropirazolo[4,3-d]pirimidin-7-onas como inibidoras de fosfodiesterase
BR9808531A (pt) Composto, processo para a preparação do mesmo, composição fungicida, processo para combater fungos em um local, e, uso de um composto ou de uma composição
WO1998056761A3 (en) Benzimidazole derivatives
YU56995A (sh) Soli derivata indola
BR9910573A (pt) Compostos antipicornavirais, preparação e uso dos mesmos
BR0315143A (pt) Composto, processo para a preparação dos (r) e (s) - enanciÈmeros individuais ou misturas de enanciÈmeros e sais farmaceuticamente aceitáveis de um composto, composição farmacêutica, e, uso de um composto
RU94038256A (ru) Производные пиразолопиримидина, способ их получения, фармацевтические композиции на их основе
BRPI0512012A (pt) composto ou um derivado farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto
BR0112267A (pt) Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto
BR9914811A (pt) Processo para a preparação de derivados de quercetina e isoquercetina
BR0011660A (pt) Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia e, processo para a preparação de um composto
BRPI0512013A (pt) composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto
BR0011673A (pt) Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia e, processo para preparação de um composto
BR0013694A (pt) Composto, processo para a preparação de um composto, composição farmacêutica, e, uso de um composto

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: DE ACORDO COM ART. 34 "II" DA LPI (LEI 9279 DE 14/05/96), O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2138 DE 27/12/2011.